
Type: RT-Antigen
CLIA: (CLIA) waived – Requires Companies CLIA Number
Test Count: 25
The INDICAID® COVID-19 Rapid Antigen Test is a lateral flow immunoassay designed for the objective identification of SARS-CoV-2 antigens. Antigen tests are designed to detect proteins from the virus that causes COVID-19 through swab specimens taken from a patient’s nose.
INDICAID® Point-of-Care (PoC) professional is a reliable indicator for COVID-19 in the laboratory, office, attended events & more.
Batch-collection & bulk-testing of individual samples
With the intuitive vial design, INDICAID® PoC (Point-of-Care) Professional Rapid Antigen Tests allow for the aggregate collection of multiple specimens followed by batch-testing of individual samples up to two (2) hours after collection, in the laboratory setting.
| Tests/Box | 25 | 
| Sample type | Anterior Nasal swab | 
| Time to results | 20 minutes | 
| Sensitivity | 97% | 
| Specificity | 84% | 
| Accuracy | 95.6% | 
| Shelf life | 12 months | 
| Storage | 36° – 86°F (2° – 30°C) | 
| CLIA complexity | Waived* | 
| Certification | FDA EUA |